About
Erin Henderson is the CEO, President, and Co-Founder of X-tosis, a biotechnology company founded in 2024 and focused on first-in-class mitochondrial therapeutics for neurodegenerative diseases including Alzheimer's, Parkinson's, and ALS. Public SEC filings also show an Erin Henderson who served as Chief Business Officer and Corporate Secretary of Blue Water Biotech and later separated from the renamed Onconetix in January 2024. The public evidence supports an operating-executive/founder profile rather than an investor profile.
Areas of interest
biotechneurodegenerationalzheimers diseaseparkinsons diseasealsmitochondrial biologyprecision medicinedrug development